Abilify Maintena

Generic name: Aripiprazole Lauroxil (injection)
Drug class: Atypical antipsychotics

Usage of Abilify Maintena

Abilify Maintena (aripiprazole) extended-release injection is used alone or in combination with other aripiprazole preparations to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions).

Abilify Maintena is also used for the ongoing treatment of people with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods)

Abilify Maintena belongs to a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Abilify Maintena is an extended-release injectable suspension of aripiprazole that only has to be given once a month.

Abilify Maintena side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

High doses or long-term use of aripiprazole can cause a serious movement disorder that may not be reversible. The longer you use Abilify Maintena, the more likely you are to develop this disorder, especially if you are a woman or an older adult.

You may have increased sexual urges, unusual urges to gamble, or other intense urges while using this medicine. Talk with your doctor if this occurs.

Abilify Maintena may cause serious side effects. Call your doctor at once if you have:

  • uncontrolled muscle movements in your face (chewing, lip smacking, frowning, tongue movement, blinking or eye movement);
  • feeling unusually hot or cold;
  • trouble swallowing;
  • a seizure;
  • feeling like you might pass out (even while lying down);
  • severe nervous system reaction - very stiff (rigid) muscles, high fever, sweating, confusion, fast or uneven heartbeats, tremors, feeling like you might pass out;
  • low blood cell counts - fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath;
  • signs of infection - fever, chills, sore throat, body aches, unusual tiredness, loss of appetite, bruising or bleeding; or
  • high blood sugar - increased thirst, increased urination, dry mouth, fruity breath odor.

    • Common Abilify Maintena side effects may include:

  • feeling restless;
  • pain where the medicine was injected;
  • weight gain; or
  • drowsiness.

    • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Abilify Maintena

    You should not be treated with Abilify Maintena if you are allergic to aripiprazole.

    Tell your doctor if you have never taken Abilify Maintena.

    Abilify Maintena may increase the risk of death in older adults with dementia-related psychosis and is not approved for this use.

    To make sure Abilify Maintena is safe for you, tell your doctor if you have ever had:

  • a problem in receiving an injection in the arm or buttocks;
  • heart disease, a heart attack or stroke;
  • high or low blood pressure;
  • high blood sugar, diabetes (in you or family member);
  • a seizure;
  • high cholesterol or triglycerides;
  • dehydration; or
  • low white blood cell (WBC) counts.

    • Using antipsychotic medicine in the last 3 months of pregnancy may cause serious problems in the newborn. Tell your doctor right away if you get pregnant. Do not stop the medicine without your doctor's advice.

    If you are pregnant, your name may be listed on a pregnancy registry to track the effects of aripiprazole on the baby.

    Ask a doctor if it is safe to breastfeed while using this medicine.

    Relate drugs

    How to use Abilify Maintena

    Usual Adult Dose for Schizophrenia:

    Aripiprazole Extended-Release IM Suspension: -Initial dose: 400 mg IM once; continue aripiprazole IR 10 to 20 mg orally once a day for 14 days -Maintenance dose: 300 to 400 mg IM once a month; the dose should not be given sooner than 26 days after the previous injection Comments: -Prior to initiating therapy with extended-release IM formulations, tolerability should be established with oral formulations; it may take up to 2 weeks to fully assess tolerability due to the half-life of aripiprazole. -The first dose of the extended-release IM formulation should be given on the same day as the initiation/re-initiation dose; providers should avoid injecting both formulations in the same deltoid or gluteal muscle. -Providers whose patients who experience adverse reactions with 400 mg/month extended-release IM suspension doses may consider reducing the dose to 300 mg/month. -Dose regimen adjustments (including addition of oral supplementation) will be needed for missed doses.

    Usual Adult Dose for Bipolar Disorder:

    Aripiprazole Extended-Release IM Suspension: -Initial dose: 400 mg IM once; continue aripiprazole IR 10 to 20 mg orally once a day for 14 days -Maintenance dose: 300 to 400 mg IM once a month; the dose should not be given sooner than 26 days after the previous injection Comments: -Providers whose patients who experience adverse reactions with 400 mg/month extended-release IM suspension doses may consider reducing the dose to 300 mg/month. -The dose recommended for maintenance treatment is the same dose needed to stabilize patients during acute treatment; healthcare providers should periodically reassess need for maintenance treatment. Uses: -Acute treatment of manic and mixed episodes associated with bipolar I disorder -Acute treatment of manic and mixed episodes of bipolar I disorder as monotherapy and as adjunct to lithium or valproate -Maintenance treatment of bipolar I disorder as monotherapy and as adjunct to lithium or valproate -Maintenance monotherapy treatment of bipolar I disorder

    Warnings

    Abilify Maintena is not approved for use in older adults with psychotic conditions related to dementia. Aripiprazole may increase the risk of death in older adults with dementia-related psychosis.

    What other drugs will affect Abilify Maintena

    Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.

    Tell your doctor about all your current medicines. Many drugs can affect Abilify Maintena, especially:

  • blood pressure medications;
  • a benzodiazepine sedative like Valium, Klonopin, or Xanax;
  • bronchodilator asthma medication;
  • cold or allergy medicine (Benadryl and others);
  • medicine to treat overactive bladder;
  • medicine to treat Parkinson's disease; or
  • medicine to treat stomach problems, motion sickness, or irritable bowel syndrome.

    • This list is not complete and many other drugs may interact with aripiprazole. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

    Popular FAQ

    Aripiprazole is one of those medications that can cause sleepiness in some people and insomnia (an inability to get to sleep) in others. Aripiprazole should be preferably taken in the morning, especially if it keeps you awake at night. Research also suggests taking it at night may antagonize D2 dopamine receptors and disrupt 24h rhythms in insulin release, possibly exacerbating metabolic dysfunction. Continue reading

    You do not administer Abilify Maintena to yourself. Abilify Maintena is an injection given only by a healthcare provider at a doctor’s office or hospital once every month. It is injected into the deltoid (upper arm) muscle or gluteal (buttock) muscle. Continue reading

    Patients who receive monthly intramuscular injections of Abilify Maintena 400 mg, and have reached steady state concentrations of the drug, can be switched to Aristada 882 mg injection four weeks after their last Abilify Maintena injection. Continue reading

    Abilify Maintena is injected into a muscle into your upper arm or buttock once a month. It is an extended-release medicine used to treat schizophrenia and bipolar I disorder in adults. It is only given by a healthcare provider in a doctor’s office or hospital. Continue reading

    Although Abilify (aripiprazole) has been found to cause less weight gain than other atypical antipsychotics, there is evidence that in certain people it can cause significant weight gain and it may be more likely to cause weight gain in people who are taking it for depression alongside other antidepressants. Side effects such as weight gain may be significant enough for some people to discontinue Abilify, even when it is working well to manage symptoms. Continue reading

    Abilify (aripiprazole) and Vraylar (cariprazine) are both classified as atypical antipsychotic medications. They help treat mental health conditions such as schizophrenia, bipolar disorder (also known as manic-depression) and as additive treatment for major depressive disorder. These medicines work by changing the actions of chemicals in the brain to help stabilize your thoughts, actions and moods. Continue reading

    The main differences between Abilify and Abilify Maintena are how they are supplied, how they are administered, their FDA-approved uses and their costs. They both contain the active ingredient aripiprazole, an atypical antipsychotic, and are approved for the treatment of schizophrenia and bipolar disorder. Continue reading

    The oral tablet formulation Abilify MyCite (aripiprazole) is embedded with the ingestible Proteus sensor that allows patients, and, if given access, doctors and caregivers, to track ingestion of the Abilify medication on a smartphone or web-based portal. The system sends a message from the pill’s sensor to a wearable patch on the patient, which then transmits to the device. Continue reading

    You do not administer Abilify Maintena to yourself. Abilify Maintena is an injection given only by a healthcare provider at a doctor’s office or hospital once every month. It is injected into the deltoid (upper arm) muscle or gluteal (buttock) muscle. Continue reading

    Aripiprazole is one of those medications that can cause sleepiness in some people and insomnia (an inability to get to sleep) in others. Aripiprazole should be preferably taken in the morning, especially if it keeps you awake at night. Research also suggests taking it at night may antagonize D2 dopamine receptors and disrupt 24h rhythms in insulin release, possibly exacerbating metabolic dysfunction. Continue reading

    Patients who receive monthly intramuscular injections of Abilify Maintena 400 mg, and have reached steady state concentrations of the drug, can be switched to Aristada 882 mg injection four weeks after their last Abilify Maintena injection. Continue reading

    Abilify Maintena is injected into a muscle into your upper arm or buttock once a month. It is an extended-release medicine used to treat schizophrenia and bipolar I disorder in adults. It is only given by a healthcare provider in a doctor’s office or hospital. Continue reading

    Although Abilify (aripiprazole) has been found to cause less weight gain than other atypical antipsychotics, there is evidence that in certain people it can cause significant weight gain and it may be more likely to cause weight gain in people who are taking it for depression alongside other antidepressants. Side effects such as weight gain may be significant enough for some people to discontinue Abilify, even when it is working well to manage symptoms. Continue reading

    Abilify (aripiprazole) and Vraylar (cariprazine) are both classified as atypical antipsychotic medications. They help treat mental health conditions such as schizophrenia, bipolar disorder (also known as manic-depression) and as additive treatment for major depressive disorder. These medicines work by changing the actions of chemicals in the brain to help stabilize your thoughts, actions and moods. Continue reading

    The main differences between Abilify and Abilify Maintena are how they are supplied, how they are administered, their FDA-approved uses and their costs. They both contain the active ingredient aripiprazole, an atypical antipsychotic, and are approved for the treatment of schizophrenia and bipolar disorder. Continue reading

    The oral tablet formulation Abilify MyCite (aripiprazole) is embedded with the ingestible Proteus sensor that allows patients, and, if given access, doctors and caregivers, to track ingestion of the Abilify medication on a smartphone or web-based portal. The system sends a message from the pill’s sensor to a wearable patch on the patient, which then transmits to the device. Continue reading

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords